Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Leutbecher

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Hematology & Oncology|September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cellsSiret Tahk, Binje Vick, Björn Hiller, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Blood|July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervalsNora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Plos Pathogens|October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Hemasphere|July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell LymphomaErik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Hematology & Oncology|September 28, 2021
SIRPα-αCD123 fusion antibodies targeting CD123 in conjunction with CD47 blockade enhance the clearance of AML-initiating cellsSiret Tahk, Binje Vick, Björn Hiller, et al.
Cancer Immunology, Immunotherapy : CII|May 22, 2025
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapyAnna Reischer, Alexandra Leutbecher, Björn Hiller, et al.
Blood|July 25, 2022
T-cell exhaustion induced by continuous bispecific molecule exposure is ameliorated by treatment-free intervalsNora Philipp, Maryam Kazerani, Alyssa Nicholls, et al.
Plos Pathogens|October 6, 2021
Impaired function and delayed regeneration of dendritic cells in COVID-19Elena Winheim, Linus Rinke, Konstantin Lutz, et al.
Nature Communications|September 23, 2022
Accumulation of mutations in antibody and CD8 T cell epitopes in a B cell depleted lymphoma patient with chronic SARS-CoV-2 infectionElham Khatamzas, Markus H Antwerpen, Alexandra Rehn, et al.
Hemasphere|July 8, 2021
COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell LymphomaErik Gaitzsch, Verena Passerini, Elham Khatamzas, et al.
Pageof 1